![AstraZeneca plans new connected inhaler trial to improve medication adherence in COPD patients | MobiHealthNews AstraZeneca plans new connected inhaler trial to improve medication adherence in COPD patients | MobiHealthNews](https://www.mobihealthnews.com/sites/default/files/Symbicort1.jpg)
AstraZeneca plans new connected inhaler trial to improve medication adherence in COPD patients | MobiHealthNews
![Symbicort® Turbuhaler® now approved by Health Canada for use in mild persistent, moderate, or severe asthma Symbicort® Turbuhaler® now approved by Health Canada for use in mild persistent, moderate, or severe asthma](https://mma.prnewswire.com/media/1002856/AstraZeneca_Symbicort__Turbuhaler__now_approved_by_Health_Canada.jpg?p=facebook)
Symbicort® Turbuhaler® now approved by Health Canada for use in mild persistent, moderate, or severe asthma
![Symbicort 200micrograms/dose / 6micrograms/dose pressurised inhaler ( AstraZeneca UK Ltd) 120 dose - RightBreathe Symbicort 200micrograms/dose / 6micrograms/dose pressurised inhaler ( AstraZeneca UK Ltd) 120 dose - RightBreathe](https://www.rightbreathe.com/wp-content/uploads/2016/12/Symibort-pressurised-inhalation-suspension-4-1280x853.jpeg)
Symbicort 200micrograms/dose / 6micrograms/dose pressurised inhaler ( AstraZeneca UK Ltd) 120 dose - RightBreathe
![SYMBICORT 160/4.5 (Budesonide, Formoterol) Dosage & Rx Info, Uses | SYMBICORT 160/4.5 Side Effects - MPR SYMBICORT 160/4.5 (Budesonide, Formoterol) Dosage & Rx Info, Uses | SYMBICORT 160/4.5 Side Effects - MPR](https://www.empr.com/wp-content/uploads/sites/7/2018/12/feb3e833ec6d49bdb68c34299c5614b3-symbicort_box_i.jpg)